Management of hyperbilirubinaemia in pancreatic cancer patients

Autor: Álvarez, R., Carrato, A., Adeva, J., Alés, I., Prados, S., Valladares, M., Macarulla, T., Muñoz, A., Hidalgo, M.

Publikováno v: In European Journal of Cancer May 2018 94:26-36

Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group

Autor: Irigoyen, A, Gallego, J, Guillen Ponce, C, Vera, R, Iranzo, V, Ales, I, Arevalo, S, Pisa, A, Martin, M, Salud, A, Falco, E, Saenz, A, Manzano Mozo, J, Pulido, G, Martinez Galan, J, Pazo-Cid, R, Rivera, F, Garcia Garcia, T, Serra, O, Fernandez Parra, E, Hurtado, A, Gomez Reina, M, Lopez Gomez, L, Martinez Ortega, E, Benavides, M, Aranda, E, Spanish Cooperative Grp Treatment

Publikováno v: EUROPEAN JOURNAL OF CANCER
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Gemcitabine and erlotinib have shown a survival benefit in the first-line setting in metastatic pancreatic cancer (mPC). The aim of this study was to assess whether combining capecitabine (C) with gemcitabine + erlotinib (GE) was safe and effective v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::8b9abf8cc0b890f41f62a1d084e9ce13
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2026

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

623PD - A phase I and randomized phase II trial to evaluate the efficacy and safety of nab-paclitaxel (nab-P) in combination with gemcitabine (G) for the treatment of patients with ECOG 2 advanced pancreatic cancer (PDAC)

Autor: Hidalgo, M., Pazo-Cid, R., Guillen-Ponce, C., López, R., Vera, R., Reboredo, M., Muñoz, A., Martinez de Castro, E., Díaz Beveridge, R., La Casta, A., Martin-Valades, J.I., Cubillo, A., Martínez-Galán, J., Ales, I., Sastre, J., Macarulla Mercade, T.

Publikováno v: In Annals of Oncology September 2017 28 Supplement 5:v212-v212

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.